February 28, 2018 / 12:14 PM / 3 months ago

BRIEF-Proqr Q4 Loss Per Share ‍Eur 0.39

Feb 28 (Reuters) - Proqr Therapeutics Nv:

* PROQR ANNOUNCES RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2017 AND PROVIDES BUSINESS UPDATE

* PROQR THERAPEUTICS NV - ‍CASH OF EUR 48.0 MILLION AT YEAR-END EXPECTED TO FUND OPERATIONS THROUGH ANTICIPATED CLINICAL DATA READOUTS IN 3 DIFFERENT PROGRAMS​

* PROQR THERAPEUTICS NV QTRLY LOSS PER SHARE ‍ EUR 0.39 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below